Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             42 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Acknowledgements 2010
6 p. 391-391
artikel
2 Acknowledgements 2009
6 p. 413-413
artikel
3 Aminoglycoside-induced mutation suppression (stop codon readthrough) as a therapeutic strategy for Duchenne muscular dystrophy Malik, Vinod
2010
6 p. 379-389
artikel
4 An update on the evidence base for peginterferon β1a in the treatment of relapsing–remitting multiple sclerosis Bhargava, Pavan
2016
6 p. 483-490
artikel
5 An update on the management of chronic inflammatory demyelinating polyneuropathy Gorson, Kenneth C.
2012
6 p. 359-373
artikel
6 An update on the management of post-traumatic headache Obermann, Mark
2015
6 p. 311-315
artikel
7 A practical approach to the diagnosis and management of sleep disorders in patients with multiple sclerosis Braley, Tiffany J.
2015
6 p. 294-310
artikel
8 Assessment scales in dementia Sheehan, Bart
2012
6 p. 349-358
artikel
9 Benefit of repetitive intrathecal triamcinolone acetonide therapy in predominantly spinal multiple sclerosis: prediction by upper spinal cord atrophy Lukas, Carsten
2009
6 p. 349-355
artikel
10 Brivaracetam as adjunctive therapy for the treatment of partial-onset seizures in patients with epilepsy: the current evidence base Brandt, Christian
2016
6 p. 474-482
artikel
11 Corrigendum 2015
6 p. 339
artikel
12 Efficacy and safety of laquinimod in multiple sclerosis: current status Haggiag, Shalom
2013
6 p. 343-352
artikel
13 Efficacy and tolerability of dimethyl fumarate in White-, African- and Hispanic- Americans with multiple sclerosis Zhovtis Ryerson, Lana
2016
6 p. 454-461
artikel
14 Erratum 2012
6 p. 375-375
artikel
15 Evidence for the efficacy of interferon beta-1b in delaying the onset of clinically definite multiple sclerosis in individuals with clinically isolated syndrome Freedman, Mark S.
2014
6 p. 279-288
artikel
16 Evidence for the use of pimavanserin in the treatment of Parkinson’s disease psychosis Sarva, Harini
2016
6 p. 462-473
artikel
17 Evolving expectations around early management of multiple sclerosis Gold, Ralf
2010
6 p. 351-367
artikel
18 Future perspectives in target-specific immunotherapies of myasthenia gravis Dalakas, Marinos C.
2015
6 p. 316-327
artikel
19 High noon back pain- severe pseudoradicular pain as a lead symptom of superficial siderosis: a case report Saft, Carsten
2014
6 p. 276-278
artikel
20 Kynurenines and other novel therapeutic strategies in the treatment of dementia Majláth, Zsófia
2013
6 p. 386-397
artikel
21 Low-dose fenfluramine in the treatment of neurologic disorders: experience in Dravet syndrome Schoonjans, An-Sofie
2015
6 p. 328-338
artikel
22 Monoclonal antibody therapies for the treatment of relapsing-remitting multiple sclerosis: differentiating mechanisms and clinical outcomes Lycke, Jan
2015
6 p. 274-293
artikel
23 MRI in the assessment and monitoring of multiple sclerosis: an update on best practice Kaunzner, Ulrike W.
2017
6 p. 247-261
artikel
24 Neurochemical biomarkers in Alzheimer’s disease and related disorders Bibl, Mirko
2012
6 p. 335-348
artikel
25 Notch signalling in adult neurons: a potential target for microtubule stabilization Bonini, Sara Anna
2013
6 p. 375-385
artikel
26 Patient preferences for disease-modifying drugs in multiple sclerosis therapy: a choice-based conjoint analysis Utz, Kathrin S.
2014
6 p. 263-275
artikel
27 Possible sites of action of the new calcitonin gene-related peptide receptor antagonists Eftekhari, Sajedeh
2010
6 p. 369-378
artikel
28 Progressive multifocal leukoencephalopathy: current treatment options and future perspectives Pavlovic, Dejan
2015
6 p. 255-273
artikel
29 Psychotic illness in patients with epilepsy Kanemoto, Kousuke
2012
6 p. 321-334
artikel
30 Quetiapine in the treatment of psychosis in Parkinson’s disease Shotbolt, Paul
2010
6 p. 339-350
artikel
31 Review: Cyclophosphamide in multiple sclerosis: scientific rationale, history and novel treatment paradigms Awad, Amer
2009
6 p. 357-368
artikel
32 Review: Deep brain stimulation in Parkinson’s disease Groiss, S.J.
2009
6 p. 379-391
artikel
33 Review: Identifying patient subtypes in multiple sclerosis and tailoring immunotherapy: challenges for the future De Jager, Philip L.
2009
6 p. 369-377
artikel
34 Review: Improving symptom control in early Parkinson’s disease Isaacson, Stuart H.
2009
6 p. 393-400
artikel
35 Review: Pathophysiology and treatment of bacterial meningitis Hoffman, Olaf
2009
6 p. 401-412
artikel
36 Rituximab combination therapy in relapsing multiple sclerosis Cross, Anne H.
2012
6 p. 311-319
artikel
37 Rituximab postprogressive multifocal leukoencephalopathy: a Feasible therapeutic option in selected cases Hoepner, Robert
2014
6 p. 289-291
artikel
38 The case for dosing dabigatran: how tailoring dose to patient renal function, weight and age could improve the benefit–risk ratio Safouris, Apostolos
2015
6 p. 245-254
artikel
39 The cognitive side of essential tremor: what are the therapeutic implications? Janicki, Sarah C.
2013
6 p. 353-368
artikel
40 The role of neuroimaging in the diagnosis of headache disorders Holle, Dagny
2013
6 p. 369-374
artikel
41 The role of pramipexole in a severe Parkinson’s disease model in mice ElHak, Seham Gad
2010
6 p. 333-337
artikel
42 Two-year real-world experience with perampanel in patients with refractory focal epilepsy: Austrian data Rohracher, Alexandra
2016
6 p. 445-453
artikel
                             42 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland